Pharma News, 2022

Eli Lilly and Incyte’s Olumiant has secured the first FDA approval for a systemic drug to treat alopecia areata, an autoimmune condition causing patchy hair loss that affects more than 700,000 p...

Dr Reddy’s Laboratories announced the launch of Dr Reddy’s Sorafenib Tablets, USP, 200 mg, a therapeutic generic equivalent of Nexavar (sorafenib) Tablets in the US market following the approva...

Health Canada has approved Amylyx Pharmaceuticals’ Albrioza (sodium phenylbutyrate and ursodoxicoltaurine) for treatment of patients with the rare progressive nervous system disease amyotrophic ...

Plastic pollution in the ocean may serve as a source for novel antibiotics, according to a new student-led study conducted in collaboration with the Scripps Institution of Oceanography.  ...

Alembic Pharmaceuticals Limited announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Dasatinib Ta...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended National Health Service (NHS) use of Amarin’s Vazkepa (icosapent ethyl) for the reduction of heart attacks or s...

As increased cases of monkeypox are being reported in the United States, the U.S. Biomedical Advanced Research and Development Authority (BARDA) has ordered an additional 500,000 additional doses o...

With the spread of monkeypox across the world coming hot on the heels of COVID-19, there are fears that increasing outbreaks of diseases that jump from animals to humans could spark another pandemi...

How do cancer cells differ from healthy cells?

The number of new coronavirus cases and deaths reported globally fell everywhere last week except the Middle East and Southeast Asia, according to the World Health Organization. ...

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for BCX9250 for the prevention of heterotopic ossificati...

Researchers have uncovered a new function for alpha-synuclein, a well-known protein marker of Parkinson’s, with relevance toward treatment for the disease. ...